Innovating Rare Disease Research with mobilehealth – A Breakthrough for Danon Disease Patients

In a groundbreaking effort to make clinical trials more accessible for patients with rare diseases, mdgroup successfully conducted mobile health visits for two brothers in Tel Aviv, Israel, diagnosed with Danon Disease—a rare genetic condition affecting mobility and cardiac health. This initiative demonstrates how mdgroup’s innovative decentralized clinical trial solutions reduce patient burden while maintaining the highest standards of data integrity and logistical efficiency.

Challenge

Danon Disease presents significant challenges for clinical trial participation due to the severe mobility issues and cardiac complications it causes. These limitations, coupled with the need for specialized testing, often require patients to travel long distances to centralized trial sites. For these two brothers, travelling from Israel to California for study screening posed a substantial physical, emotional, and logistical burden.

Additionally, the trial protocol required the collection and shipment of sensitive biological samples to three different international locations: Finland, Switzerland, and the United States. Ensuring the integrity and viability of these samples across such vast distances demanded meticulous coordination and expertise.

Solution

To address these challenges, mdgroup deployed its mobilehealth services, bringing the clinical trial directly to the patients. Key elements of the solution included:

Remote Screening Visits:

• mdgroup conducted study screening remotely, utilizing its team of highly trained healthcare professionals to perform all necessary tests in the comfort of the brothers’ home.

• This eliminated the need for international travel, significantly reducing the burden on the patients and their families.

Streamlined Logistics for Sample Handling:

• mdgroup’s in-house logistics team meticulously planned the collection, packaging, and shipping of biological samples.

• Samples were transported from Tel Aviv to specialized laboratories in Finland, Switzerland, and the US, ensuring they arrived within strict timeframes and in optimal condition.

Patient-Centric Approach:

• The brothers were supported by mdgroup Navigators, who managed every aspect of the process, from scheduling visits to providing ongoing communication and reassurance.

• A focus on empathy and flexibility ensured that the experience was as seamless and stress-free as possible for the family.

Outcome

This initiative not only enabled the brothers to participate in the study without leaving their home country but also demonstrated the power of decentralized clinical trials to overcome barriers traditionally associated with rare disease research. By:

• Successfully completing the remote screening process, mdgroup ensured the brothers’ eligibility for the trial.

• Achieving seamless international shipping and data management, mdgroup upheld the integrity and accuracy of the trial data.

• Reducing patient travel, mdgroup improved patient satisfaction and retention, key factors for trial success.

Impact

The successful implementation of this project highlights mdgroup’s commitment to innovation in decentralized clinical trials, providing critical access for rare disease patients who would otherwise face insurmountable challenges.

• For the patients: Enabled participation in life-changing research while preserving their quality of life.

• For the sponsor: Delivered high-quality data without compromising timelines or budgets.

• For the industry: Demonstrated the scalability and effectiveness of mobile health solutions for complex, global trials.

Conclusion

The case of these two brothers with Danon Disease exemplifies how mdgroup is transforming the clinical trial landscape, ensuring no patient is left behind. By putting patients first, embracing technology, and maintaining a relentless focus on quality, mdgroup is redefining what’s possible in rare disease research.

Want to find out more about our remarkable patient experiences?

We’re on a mission to put patients first in clinical research worldwide. Through our personalised patient-focused services and technologies, we support patients at every stage of the clinical journey.

Our approach to facilitating remarkable patient experiences in clinical trials drastically reduces drop-out rates and boosts clinical outcomes. Get in touch to discover more.